- Home
- ANVS vs CLPR Comparison
ANVS vs CLPR Comparison
Compare ANVS & CLPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANVS
- CLPR
- Stock Information
- Founded
- ANVS 2008
- CLPR 2015
- Country
- ANVS United States
- CLPR United States
- Employees
- ANVS N/A
- CLPR N/A
- Industry
- ANVS Biotechnology: Pharmaceutical Preparations
- CLPR Real Estate Investment Trusts
- Sector
- ANVS Health Care
- CLPR Real Estate
- Exchange
- ANVS Nasdaq
- CLPR Nasdaq
- Market Cap
- ANVS 92.6M
- CLPR 78.3M
- IPO Year
- ANVS 2020
- CLPR 2017
- Fundamental
- Price
- ANVS $2.13
- CLPR $4.46
- Analyst Decision
- ANVS Strong Buy
- CLPR Sell
- Analyst Count
- ANVS 6
- CLPR 2
- Target Price
- ANVS $31.40
- CLPR N/A
- AVG Volume (30 Days)
- ANVS 684.1K
- CLPR 90.1K
- Earning Date
- ANVS 03-31-2025
- CLPR 02-14-2025
- Dividend Yield
- ANVS N/A
- CLPR 8.97%
- EPS Growth
- ANVS N/A
- CLPR N/A
- EPS
- ANVS N/A
- CLPR N/A
- Revenue
- ANVS N/A
- CLPR $148,775,000.00
- Revenue This Year
- ANVS N/A
- CLPR N/A
- Revenue Next Year
- ANVS N/A
- CLPR N/A
- P/E Ratio
- ANVS N/A
- CLPR N/A
- Revenue Growth
- ANVS N/A
- CLPR 7.65
- 52 Week Low
- ANVS $2.08
- CLPR $3.38
- 52 Week High
- ANVS $20.00
- CLPR $7.12
- Technical
- Relative Strength Index (RSI)
- ANVS 18.43
- CLPR 54.29
- Support Level
- ANVS $2.08
- CLPR $3.86
- Resistance Level
- ANVS $2.79
- CLPR $5.16
- Average True Range (ATR)
- ANVS 0.32
- CLPR 0.29
- MACD
- ANVS -0.06
- CLPR 0.11
- Stochastic Oscillator
- ANVS 2.08
- CLPR 46.15
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for advanced AD.
About CLPR Clipper Realty Inc.
Clipper Realty Inc is a self-administered and self-managed real estate company. It acquires, owns, manages, operates, and repositions multifamily residential and commercial properties in the New York metropolitan area, with a portfolio in Manhattan and Brooklyn. It has classified its reporting segments into Residential Rental Properties and Commercial Rental Properties. The company derives its revenue mostly from the Residential segment.